Murat Yildirim

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

Matthew Harlin, Murat Yildirim, Pedro Such et al. · CNS Drugs · 2023 · 34 citations · Full text

An alternative start regimen with aripiprazole once-monthly in patients with schizophrenia: population pharmacokinetic analysis of a single-day, two-injection start with gluteal and/or deltoid intramuscular injection

Yanlin Wang, Xiaofeng Wang, Matthew Harlin et al. · Current Medical Research and Opinion · 2021 · 16 citations

Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study

Roger S. McIntyre, Pedro Such, Murat Yildirim et al. · Current Medical Research and Opinion · 2023 · 10 citations · Full text

Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison

Matthew Harlin, Craig Chepke, Frank Larsen et al. · Neuropsychiatric Disease and Treatment · 2023 · 10 citations · Full text